Mallinckrodt Pharmaceuticals, Mylan Pharmaceutical AG and Medtronic Sandoz is involved in research and development efforts related to endocrine disorders, including adrenal insufficiency. The company ...

Fennec Pharmaceuticals (Nasdaq: FENC) has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. Terry Evans joins as ...

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, ...

Rigel Pharmaceuticals (RIGL) is issuing a Dear Health Care Provider – DHCP – letter related to a new safety signal for Gavreto – pralsetinib – after consultation with the FDA. Gavreto is ...

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL), a commercial stage biotechnology company focused on ...

A pharmaceutical body has warned of potential shortages of some medicines in Northern Ireland unless there is a delay to the implementation of the Windsor Framework. The framework is the post ...

Cipher Pharmaceuticals is a specialty company with a focus on dermatology. The Canadian company is acquiring and developing products with the stated aim of changing the face of dermatology treatment ...

Comparatively, Pieris Pharmaceuticals has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. 70.5% of Notable Labs shares are owned by institutional investors.